HRTX Net Income Growth
Heron Therapeutics Inc · Net Income Growth
HRTX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-3557.25%period ending
HRTX TTM Net Income YoY % (-31.58% → -3557.25%)
Year-over-year change
High-resolution chart · PNG
HRTX net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -3,557.2503% | |
| -297.4438% | |
| -48.7113% | |
| 51.4499% | |
| 98.0655% | |
| 90.3831% | |
| 87.717% | |
| 76.6365% | |
| 64.769% | |
| 46.356% | |
| 39.2613% | |
| 44.7862% | |
| 39.9017% | |
| 34.9431% | |
| 17.5179% | |
| 5.0443% | |
| 2.9201% | |
| -1.5961% | |
| 2.9017% | |
| -2.4229% | |
| -18.0821% | |
| -18.1035% | |
| -11.0032% | |
| -13.5085% | |
| 1.4194% | |
| -1.9669% | |
| -14.4873% | |
| -2.4076% | |
| -2.9945% | |
| 4.9308% | |
| 9.4408% | |
| -4.8175% | |
| -3.0016% | |
| -4.943% | |
| -14.0583% | |
| -16.9637% | |
| -45.1928% | |
| -72.0231% | |
| -77.417% | |
| -79.8512% | |
| -56.3986% | |
| -39.1277% | |
| -27.7921% | |
| -24.6264% | |
| -31.5586% | |
| -32.6234% | |
| -38.1383% | |
| -42.4922% | |
| -50.3079% | |
| -90.7839% | |
| -136.7783% | |
| -146.4573% | |
| -135.1919% | |
| -104.8838% | |
| -97.6299% | |
| -117.2041% | |
| -171.2343% | |
| -85.1995% | |
| -60.8222% | |
| -19.3919% | |
| 8.1332% | |
| -9.3481% | |
| 26.7451% | |
| 36.4646% | |
| 57.7469% | |
| 60.6933% | |
| 56.6357% | |
| 55.1302% | |
| 32.7603% | |
| 8.4024% | |
| -14.6903% | |
| -48.2789% | |
| -46.9293% | |
| -4.8518% | |
| -482.8902% | |
| -317.6492% | |
| -265.9296% | |
| -262.2975% | |
| 164.1335% | |
| 205.8996% | |
| 229.3459% | |
| 256.6895% | |
| 10.9533% | |
| 5.7181% | |
| -7.5277% | |
| -12.6233% | |
| -111.3939% | |
| -159.7945% | |
| -133.3541% | |
| -155.4785% | |
| -15.4579% | |
| 38.6863% | |
| -18.9681% | |
| -14.1785% | |
| -50.3382% | |
| -116.4944% | |
| -140.5235% | |
| -133.2547% | |
| -129.3839% | |
| -120.9541% |